Papers
1
Total Citations
4
H-Index
1
About
Dr. Qijun Wo is a pioneering urologic surgeon whose work centers on advancing nephron-sparing surgery for renal cell carcinoma. His most impactful contribution lies in refining the technique of zero ischaemia robotic-assisted laparoscopic partial nephrectomy (RALPN) for T1 renal tumors. By integrating preoperative superselective transarterial embolization (STE), Dr. Wo demonstrated a feasible and safe method to minimize renal ischemia during tumor resection, thereby preserving maximum kidney function. His 2023 study, which has garnered early citations for its clinical significance, analyzed data from 32 patients and established a protocol that reduces operative risks without compromising oncologic outcomes. This work addresses a critical challenge in urologic oncology: balancing complete tumor excision with renal parenchymal preservation. Dr. Wo’s research has direct implications for improving postoperative renal function and quality of life in kidney cancer patients. As a rising authority in robotic surgery and interventional radiology integration, his contributions are shaping the future of minimally invasive urologic procedures, offering a promising alternative to traditional warm ischemia techniques.
Research Focus
Key Achievements
Top Papers
- 1